Winston Represents Nonbinary Runner Cal Calamia in Securing Groundbreaking Therapeutic Use Exemption From USADA

NEW YORK--(BUSINESS WIRE)--Winston & Strawn LLP prevailed on behalf of nonbinary runner Cal Calamia in securing United States Anti-Doping Agency (USADA) approval of a Therapeutic Use Exemption (TUE) for Calamia’s use of testosterone in male, nonbinary, and open running categories. The USADA issued the approval on October 5, 2023. Calamia, who uses both “he” and “they” pronouns, has been taking testosterone as part of his gender transition after having been assigned female at birth. Winston